Breaking News
Start for Free 0
🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% each
Unlock Stocks
Close

Sartorius Stedim Biotech SA (STDM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
182.50 -3.10    -1.67%
16:35:03 - Closed. Currency in EUR
  • Volume: 65,849
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 180.65 - 185.80
Type:  Equity
Market:  France
ISIN:  FR0013154002 
Sartorius Stedim 182.50 -3.10 -1.67%

Sartorius Stedim (EPA:STDM) Annual Report

 
This summary provides an overview of the most significant critical numbers from each of the Sartorius Stedim financial reports, including the Sartorius Stedim Biotech SA income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the EPA:STDM financials over time via breakdowns of their annual reports. Advanced annual reports and additional financial summaries (including visual charts) are available to users with an InvestingPro account.

Sartorius Stedim Biotech S.A. reported earnings results for the third quarter and nine months ended September 30, 2024. For the third quarter, the company reported sales was EUR 655.4 million compared to EUR 666.9 million a year ago. Net income was EUR 25.5 million compared to EUR 34.4 million a year ago. Basic earnings per share from continuing operations was EUR 0.26 compared to EUR 0.37 a year ago. Diluted earnings per share from continuing operations was EUR 0.26 compared to EUR 0.37 a year ago. For the nine months, sales was EUR 2,028.7 million compared to EUR 2,068.7 million a year ago. Net income was EUR 129.5 million compared to EUR 278.6 million a year ago. Basic earnings per share from continuing operations was EUR 1.34 compared to EUR 3.02 a year ago. Diluted earnings per share from continuing operations was EUR 1.34 compared to EUR 3.02 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

%SHORT_NAME% (STDM) Income Statement & Profits

Gross margin TTM 43.33%
Operating margin TTM 14.58%
Net Profit margin TTM 5.87%
Return on Investment TTM 4.47%
 Total Revenue  Net Income
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Revenue 655.4 706.4 666.9 706.8
Gross Profit 275.4 306.3 308.4 253.2
Operating Income 70.7 104.4 110 125.1
Net Income 25.5 47.6 56.1 39.8

STDM Annual Report (Balance Sheet)

Quick Ratio MRQ 1
Current Ratio MRQ 2.14
LT Debt to Equity MRQ 68.78%
Total Debt to Equity MRQ 72.57%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Assets 7997.5 8068.9 8439.3 7739.9
Total Liabilities 4058.7 4144.6 4572.4 5066.7
Total Equity 3938.8 3924.3 3866.9 2673.2

%SHORT_NAME% (STDM) Latest Cash Flow Statement

Cash Flow/Share TTM 8.9
Revenue/Share TTM 28.11
Operating Cash Flow  34.11%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 258.5 216.3 55.4 336
Cash From Investing Activities -70.4 -80.2 -109.2 -105.2
Cash From Financing Activities -159.8 -376.2 632.3 -213.9
Net Change in Cash 28.5 -241 578.4 17.3
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Sartorius Stedim (STDM) Price Discussion

Write your thoughts about Sartorius Stedim Biotech SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email